MANE NYSE
Veradermics, Incorporated
1W: +10.6%
1M: +22.3%
3M: +30.5%
YTD: +272.6%
$140.72
+3.33 (+2.42%)
Weekly Expected Move ±12.8%
$103
$121
$139
$157
$175
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (96)
Why This Hair Restoration Biotech's Shares Are Soaring
Veradermics (NYSE:MANE) Shares Gap Up Following Analyst Upgrade
Veradermics scores another late-stage trial win for hair loss therapy
Veradermics, Incorporated (NYSE:MANE) Stock Has Consensus Price Target of $153.00 According to Analysts
MANE Stock Jumps As Traders Zero In On Momentum - StocksToTrade
MANE Stock Surges As Traders Target Volatile Breakout - Timothy Sykes
MANE Stock Jumps As Traders Pile Into Volatile Breakout - Timothy Sykes
MANE Stock Pops On Volatile Rally As Traders Pile In - StocksToTrade
Veradermics (NYSE:MANE) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat
Veradermics (NYSE:MANE) Stock Jumps 3.4% - Time to Buy? - MarketBeat
Veradermics (NYSE:MANE) Stock Falls 8.1% - Here's What Happened - MarketBeat
MANE Oct 2026 120.000 call (MANE261016C00120000) Stock Price, News, Quote & History - Yahoo! Finance Canada
MANE Oct 2026 80.000 put (MANE261016P00080000) Stock Price, News, Quote & History - Yahoo! Finance Canada
Top Veradermics (MANE) Competitors 2026 - MarketBeat
MANE Oct 2026 100.000 put (MANE261016P00100000) Interactive Stock Chart - Yahoo! Finance Canada
Veradermics (NYSE:MANE) Stock Forecast & Analyst Predictions - Simply Wall Street
Novo eyes hair-loss market as Ozempic maker looks to diversify
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of “Moderate Buy” from Brokerages
Veradermics: Buy Before The Catalysts (NYSE:MANE) - Seeking Alpha
Veradermics to Present at Upcoming September Investor Conferences
Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally
Is Veradermics (MANE) Still Undervalued After Its 161% Year To Date Run?
Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally - Yahoo Finance
Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANE
$MANE stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
Insider Sale: Director at $MANE Sells 690,601 Shares - Moomoo
Insider Selling: Veradermics (NYSE:MANE) Director Sells $10,712,000.00 in Stock
Veradermics reports Q2 results
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Veradermics (MANE) Positioned to Disrupt Hair Loss Market
Veradermics, Incorporated’s Lock-Up Period Set To End on August 3rd (NYSE:MANE)
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
Veradermics (NYSE:MANE) Shares Gap Up After Analyst Upgrade
Why Veradermics Stock Fell Today - Quiver Quantitative
Veradermics (MANE) Sees 13.9% Increase in Stock Price - GuruFocus
Veradermics Hair Loss Pill Shows Strong Phase II Signal in Women
Veradermics reports phase 2 hair loss trial results - Investing.com
Up to 90% of women reported better hair coverage by Month 6 - Stock Titan
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
Why Is MANE Stock Rising Today? - Stocktwits
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
Female Pattern Hair-Loss Results Set for Veradermics Webcast - Stock Titan
MSN Money - MSN
Watch Stock Markets: State Street to Continue Buying Tech Dips, Veitmane Says - Bloomberg.com
Veradermics (MANE) Stock Forecast & Analyst Ratings - Moomoo
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Cantor Fitzgerald reiterates Veradermics stock rating after CEO dinner - Investing.com
Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect?
Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect?
Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Should I buy Veradermics Incorporated (MANE) - Zacks Investment Research
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now?
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now?
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now? - Yahoo Finance
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
Hair-loss drug firm Veradermics lines up June investor talks - Stock Titan
Viking Stake In Veradermics Highlights Risky Growth And Ownership Shifts
Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026
Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026 - Yahoo Finance
The IPO Boom Isn’t in Tech and AI—Yet
Veradermics Hair Loss Data And Funding Reignite Interest In MANE Stock - simplywall.st
Citi Remains Bullish on Veradermics, Incorporated (MANE)
Citi Remains Bullish on Veradermics, Incorporated (MANE)
Citi Remains Bullish on Veradermics, Incorporated (MANE) - Yahoo Finance
MaxLinear is the best performing mid cap stock
Organon & Co is the best performing healthcare stock in April
MANE Study 302: Veradermics Posts Positive Top-Line Phase II/III Results for Oral Minoxidil Pill
Veradermics (MANE) Reports Positive Phase 2/3 Results for Male Pattern Hair Loss Treatment VDPHL01
Veradermics prices upsized $384M public offering and $30M private placement at $100/share
Newly Listed Veradermics Hair Loss Drug Shows Hair Growth Gains
Veradermics announces launch of public offering
Biotech Skyrockets Nearly 50% On A Potential Game-Changer In Hair Loss
12 Health Care Stocks Moving In Monday's Intraday Session
Crude Oil Gains Over 1%; Verizon Posts Upbeat Earnings
Newly Listed Veradermics Hair Loss Drug Shows Hair Growth Gains
Veradermics Shares Jump 17% on Promising Hair Loss Trial Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
Veradermics Shares Jump 17% on Promising Hair Loss Trial Results - Yahoo Finance
Assessing Veradermics (MANE) Valuation After Strong Year To Date Gains And Recent Pullback
Jim Cramer on Veradermics: “It’s Double or Nothing With MANE”
Jim Cramer on Veradermics: “It’s Double or Nothing With MANE” - Yahoo Finance
Veradermics (MANE) Reports Q4 Net Loss of $21.8M
MANE Stock Price and Chart — NYSE:MANE - TradingView
Tango Therapeutics is the best performing healthcare stock in March
Veradermics reports Q4 results
Is Veradermics (MANE) Pricing Look Attractive After Recent Pharma Sector Reappraisal?
Catalyst Watch: Jobs report, new Apple products, and a spotlight on software
Assessing Veradermics (MANE) Valuation After Recent Share Price Move And Persistent Pre Revenue Losses - Yahoo Finance
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
Veradermics, Incorporated (MANE) stock price, news, quote and history - Yahoo Finance UK
Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
Veradermics, Incorporated (MANE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Veradermics Announces Pricing of Upsized Initial Public Offering
symbol__ Stock Quote Price and Forecast - CNN